{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:42:58Z","timestamp":1791434578240,"version":"4.3.3"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>The postoperative course of patent ductus arteriosus ligation is often complicated by postligation cardiac syndrome, occurring in 10\u201345% of operated infants. Milrinone might prevent profound hemodynamic instability and improve the recovery of cardiac function in this setting. The present study aimed to describe the population pharmacokinetics of milrinone in premature neonates at risk of postligation cardiac syndrome and give dosing recommendations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>A prospective single group open-label pharmacokinetics study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Settings:<\/jats:title>\n            <jats:p>Two tertiary care neonatal ICUs: Tallinn Children\u2019s Hospital and Tartu University Hospital, Estonia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Ten neonates with postmenstrual age of 24.6\u201330.1 weeks and postnatal age of 5\u201327 days undergoing patent ductus arteriosus ligation and at risk of postligation cardiac syndrome, based on echocardiographic assessment of left ventricular output of less than 200\u2009mL\/kg\/min 1 hour after the surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Milrinone at a dose of 0.73 \u03bcg\/kg\/min for 3 hours followed by 0.16 \u03bcg\/kg\/min for 21 hours. Four blood samples from each patient for milrinone plasma concentration measurements were collected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Concentration-time data of milrinone were analyzed with nonlinear mixed-effects modeling software (NONMEM Version 7.3 [ICON Development Solutions, Ellicott City, MD]). Probability of target attainment simulations gave a dosing schedule that maximally attains concentration targets of 150\u2013250 \u03bcg\/L. Milrinone pharmacokinetics was described by a one-compartmental linear model with allometric scaling to bodyweight and an age maturation function of glomerular filtration rate. Parameter estimates for a patient with the median weight were 0.350 (L\/hr) for clearance and 0.329 (L) for volume of distribution. The best probability of target attainment was achieved with a loading dose of 0.50 \u03bcg\/kg\/min for 3 hours followed by 0.15 \u03bcg\/kg\/min (postmenstrual age &lt; 27\u2009wk) or 0.20 \u03bcg\/kg\/min (postmenstrual age \u2265 27\u2009wk).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Population pharmacokinetic modeling and simulations suggest a slow loading dose followed by maintenance infusion to reach therapeutic milrinone plasma concentrations within the timeframe of the postligation cardiac syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000001879","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T20:40:50Z","timestamp":1548276050000},"page":"621-629","source":"Crossref","is-referenced-by-count":9,"title":["Population Pharmacokinetics and Dosing of Milrinone After Patent Ductus Arteriosus Ligation in Preterm Infants"],"prefix":"10.1097","volume":"20","author":[{"given":"Maarja","family":"Hallik","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia."},{"name":"Clinic of Paediatrics, Tallinn Children\u2019s Hospital, Tallinn, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari-Liis","family":"Ilmoja","sequence":"additional","affiliation":[{"name":"Clinic of Paediatrics, Tallinn Children\u2019s Hospital, Tallinn, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00f5nis","family":"Tasa","sequence":"additional","affiliation":[{"name":"Institute of Computer Science, University of Tartu, Tartu, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Standing","sequence":"additional","affiliation":[{"name":"Inflammation, Infection and Rheumatology section, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalev","family":"Takkis","sequence":"additional","affiliation":[{"name":"Analytical Services International, St George\u2019s University of London, Cranmer Terrace, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u016bta","family":"Veigure","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Tartu, Tartu, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kipper","sequence":"additional","affiliation":[{"name":"Analytical Services International, St George\u2019s University of London, Cranmer Terrace, London, United Kingdom."},{"name":"Institute of Chemistry, University of Tartu, Tartu, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiiu","family":"Jalas","sequence":"additional","affiliation":[{"name":"Clinic of Paediatrics, Tallinn Children\u2019s Hospital, Tallinn, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maila","family":"Raidm\u00e4e","sequence":"additional","affiliation":[{"name":"Clinic of Paediatrics, Tallinn Children\u2019s Hospital, Tallinn, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Uibo","sequence":"additional","affiliation":[{"name":"Clinic of Paediatrics, Tallinn Children\u2019s Hospital, Tallinn, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Starkopf","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia."},{"name":"Clinic of Anaesthesiology and Intensive Care, Tartu University Hospital, Tartu, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuli","family":"Metsvaht","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia."},{"name":"Clinic of Anaesthesiology and Intensive Care, Tartu University Hospital, Tartu, Estonia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/pr.2016.166","article-title":"Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.","volume":"80","author":"Hagadorn","year":"2016","journal-title":"Pediatr Res"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0036-1593351","article-title":"Trends and outcomes of patent ductus arteriosus treatment in very preterm infants in Canada.","volume":"34","author":"Lokku","year":"2017","journal-title":"Am J Perinatol"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1017\/S1047951115001869","article-title":"Surgical ligation of patent ductus arteriosus in premature infants: Trends and practice variation.","volume":"26","author":"Weinberg","year":"2016","journal-title":"Cardiol Young"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.earlhumdev.2017.07.011","article-title":"Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.","volume":"113","author":"Boghossian","year":"2017","journal-title":"Early Hum Dev"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41372-018-0056-4","article-title":"Post-ligation cardiac syndrome is associated with increased morbidity in preterm infants.","volume":"38","author":"Ulrich","year":"2018","journal-title":"J Perinatol"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jpeds.2007.01.035","article-title":"Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants.","volume":"150","author":"Noori","year":"2007","journal-title":"J Pediatr"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jtcvs.2010.01.011","article-title":"Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000\u2009g.","volume":"140","author":"McNamara","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/jp.2014.151","article-title":"Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation.","volume":"35","author":"Noori","year":"2015","journal-title":"J Perinatol"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jpeds.2012.12.094","article-title":"Ligation of the patent ductus arteriosus in preterm infants: Understanding the physiology.","volume":"162","author":"El-Khuffash","year":"2013","journal-title":"J Pediatr"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/jp.2008.101","article-title":"Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention.","volume":"28","author":"Teixeira","year":"2008","journal-title":"J Perinatol"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2011.09.027","article-title":"Use of targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus arteriosus ligation.","volume":"160","author":"Jain","year":"2012","journal-title":"J Pediatr"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jps.2600731029","article-title":"Oral and intravenous pharmacokinetics of milrinone in human volunteers.","volume":"73","author":"Stroshane","year":"1984","journal-title":"J Pharm Sci"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jpeds.2014.03.048","article-title":"Assessment and treatment of post patent ductus arteriosus ligation syndrome.","volume":"165","author":"El-Khuffash","year":"2014","journal-title":"J Pediatr"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00431-010-1296-2","article-title":"Use of milrinone in the management of haemodynamic instability following duct ligation.","volume":"170","author":"Sehgal","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14767058.2016.1177720","article-title":"Milrinone use for hemodynamic instability in patent ductus arteriosus ligation.","volume":"30","author":"Halliday","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jtcvs.2016.03.085","article-title":"Predictors of respiratory instability in neonates undergoing patient ductus arteriosus ligation after the introduction of targeted milrinone treatment.","volume":"152","author":"Ting","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000447049","article-title":"Dosing of milrinone in preterm neonates to prevent postligation cardiac syndrome: Simulation study suggests need for bolus infusion.","volume":"111","author":"Hallik","year":"2017","journal-title":"Neonatology"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PCC.0b013e31824ea2cd","article-title":"Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide.","volume":"14","author":"McNamara","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1136\/adc.2005.092817","article-title":"Population pharmacokinetics and dosing regimen design of milrinone in preterm infants.","volume":"92","author":"Paradisis","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3476(98)70454-8","article-title":"Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.","volume":"132","author":"Lindsay","year":"1998","journal-title":"J Pediatr"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1213\/00000539-199802000-00011","article-title":"Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery.","volume":"86","author":"Ramamoorthy","year":"1998","journal-title":"Anesth Analg"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:JOPA.0000029488.45177.48","article-title":"A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery.","volume":"31","author":"Bailey","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1213\/01.ane.0000198626.67391.34","article-title":"Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction.","volume":"102","author":"Zuppa","year":"2006","journal-title":"Anesth Analg"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.echo.2012.07.016","article-title":"Acute changes in myocardial systolic function in preterm infants undergoing patent ductus arteriosus ligation: A tissue Doppler and myocardial deformation study.","volume":"25","author":"El-Khuffash","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"317","DOI":"10.21037\/cdt.2017.03.12","article-title":"Assessing observer variability: A user\u2019s guide.","volume":"7","author":"Popovi\u0107","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bcp.13160","article-title":"Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?","volume":"83","author":"Germovsek","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","article-title":"Human renal function maturation: A quantitative description using weight and postmenstrual age.","volume":"24","author":"Rhodin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1128\/AAC.00577-16","article-title":"Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants.","volume":"60","author":"Germovsek","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20230823","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dky128","article-title":"Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: Results from the NeoMero studies.","author":"Germovsek","year":"2018 Apr 19","journal-title":"J Antimicrob Chemother"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40262-013-0096-z","article-title":"Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.","volume":"53","author":"Vogt","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"R32-20230823","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.23574","article-title":"A pharmacokinetic standard for babies and adults.","volume":"102","author":"Holford","year":"2013","journal-title":"J Pharm Sci"},{"key":"R33-20230823","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02238-17","article-title":"Pharmacokinetics of penicillin G in preterm and term neonates.","volume":"62","author":"Padari","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/cpt.621","article-title":"Predicting CD4 T-cell reconstitution following pediatric hematopoietic stem cell transplantation.","volume":"102","author":"Hoare","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2165\/00003495-198836020-00003","article-title":"Milrinone. A preliminary review of its pharmacological properties and therapeutic use.","volume":"36","author":"Young","year":"1988","journal-title":"Drugs"},{"key":"R36-20230823","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1460-9592.2011.03536.x","article-title":"Tips and traps analyzing pediatric PK data.","volume":"21","author":"Anderson","year":"2011","journal-title":"Paediatr Anaesth"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1651-2227.1989.tb11280.x","article-title":"Postnatal weight loss in preterm neonates less than 1,500\u2009g is due to isotonic dehydration of the extracellular volume.","volume":"360","author":"Bauer","year":"1989","journal-title":"Acta Paediatr Scand Suppl"},{"key":"R38-20230823","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00228-008-0599-y","article-title":"Clinical pharmacokinetics of aminoglycosides in the neonate: A review.","volume":"65","author":"Pacifici","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"R39-20230823","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00467-005-2105-4","article-title":"Ontogeny of drug elimination by the human kidney.","volume":"21","author":"Chen","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R40-20230823","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpeds.2008.07.059","article-title":"Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants.","volume":"154","author":"Paradisis","year":"2009","journal-title":"J Pediatr"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201907000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:47:07Z","timestamp":1692838027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201907000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001879","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}